JPH10216220A - Medical treatment implement - Google Patents
Medical treatment implementInfo
- Publication number
- JPH10216220A JPH10216220A JP9023865A JP2386597A JPH10216220A JP H10216220 A JPH10216220 A JP H10216220A JP 9023865 A JP9023865 A JP 9023865A JP 2386597 A JP2386597 A JP 2386597A JP H10216220 A JPH10216220 A JP H10216220A
- Authority
- JP
- Japan
- Prior art keywords
- medical device
- resin coating
- end side
- frictional resistance
- lubricating resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920005989 resin Polymers 0.000 claims abstract description 54
- 239000011347 resin Substances 0.000 claims abstract description 54
- 238000000576 coating method Methods 0.000 claims abstract description 51
- 239000011248 coating agent Substances 0.000 claims abstract description 48
- 238000003780 insertion Methods 0.000 claims abstract description 11
- 230000037431 insertion Effects 0.000 claims abstract description 11
- 230000001050 lubricating effect Effects 0.000 claims description 48
- 230000007423 decrease Effects 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 abstract description 40
- -1 carboxyl methyl Chemical group 0.000 abstract description 9
- 229920002472 Starch Polymers 0.000 abstract description 4
- 239000008107 starch Substances 0.000 abstract description 4
- 235000019698 starch Nutrition 0.000 abstract description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 abstract description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 abstract description 3
- 239000002861 polymer material Substances 0.000 abstract 1
- 239000002585 base Substances 0.000 description 24
- 239000000126 substance Substances 0.000 description 21
- 229920003169 water-soluble polymer Polymers 0.000 description 18
- 239000000758 substrate Substances 0.000 description 17
- 239000000463 material Substances 0.000 description 15
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 13
- 239000002904 solvent Substances 0.000 description 12
- 125000000524 functional group Chemical group 0.000 description 11
- 229910052751 metal Inorganic materials 0.000 description 9
- 239000002184 metal Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 125000003700 epoxy group Chemical group 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 230000001747 exhibiting effect Effects 0.000 description 4
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 229920002647 polyamide Polymers 0.000 description 4
- 229920000768 polyamine Polymers 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- 125000003172 aldehyde group Chemical group 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- KHYBPSFKEHXSLX-UHFFFAOYSA-N iminotitanium Chemical group [Ti]=N KHYBPSFKEHXSLX-UHFFFAOYSA-N 0.000 description 3
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 3
- 229920000620 organic polymer Polymers 0.000 description 3
- 229920000098 polyolefin Polymers 0.000 description 3
- 229920005749 polyurethane resin Polymers 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- ICGQLNMKJVHCIR-UHFFFAOYSA-N 1,3,2-dioxazetidin-4-one Chemical group O=C1ONO1 ICGQLNMKJVHCIR-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical group CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- 125000004018 acid anhydride group Chemical group 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical group [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 125000002081 peroxide group Chemical group 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001228 polyisocyanate Polymers 0.000 description 2
- 239000005056 polyisocyanate Substances 0.000 description 2
- 239000002952 polymeric resin Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- MTZUIIAIAKMWLI-UHFFFAOYSA-N 1,2-diisocyanatobenzene Chemical compound O=C=NC1=CC=CC=C1N=C=O MTZUIIAIAKMWLI-UHFFFAOYSA-N 0.000 description 1
- ZTNJGMFHJYGMDR-UHFFFAOYSA-N 1,2-diisocyanatoethane Chemical compound O=C=NCCN=C=O ZTNJGMFHJYGMDR-UHFFFAOYSA-N 0.000 description 1
- ZXHZWRZAWJVPIC-UHFFFAOYSA-N 1,2-diisocyanatonaphthalene Chemical compound C1=CC=CC2=C(N=C=O)C(N=C=O)=CC=C21 ZXHZWRZAWJVPIC-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- PWGJDPKCLMLPJW-UHFFFAOYSA-N 1,8-diaminooctane Chemical compound NCCCCCCCCN PWGJDPKCLMLPJW-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
- VVJIVFKAROPUOS-UHFFFAOYSA-N 2,2-bis(aminomethyl)propane-1,3-diamine Chemical compound NCC(CN)(CN)CN VVJIVFKAROPUOS-UHFFFAOYSA-N 0.000 description 1
- NTINFTOOVNKGIU-UHFFFAOYSA-N 2-(2-hydroxyethoxycarbonyl)benzoic acid Chemical compound OCCOC(=O)C1=CC=CC=C1C(O)=O NTINFTOOVNKGIU-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- GHKSKVKCKMGRDU-UHFFFAOYSA-N 2-(3-aminopropylamino)ethanol Chemical compound NCCCNCCO GHKSKVKCKMGRDU-UHFFFAOYSA-N 0.000 description 1
- DPBJAVGHACCNRL-UHFFFAOYSA-N 2-(dimethylamino)ethyl prop-2-enoate Chemical compound CN(C)CCOC(=O)C=C DPBJAVGHACCNRL-UHFFFAOYSA-N 0.000 description 1
- OZDGMOYKSFPLSE-UHFFFAOYSA-N 2-Methylaziridine Chemical compound CC1CN1 OZDGMOYKSFPLSE-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- HSDVRWZKEDRBAG-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COC(CCCCC)OCC1CO1 HSDVRWZKEDRBAG-UHFFFAOYSA-N 0.000 description 1
- HDPLHDGYGLENEI-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC1CO1 HDPLHDGYGLENEI-UHFFFAOYSA-N 0.000 description 1
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 1
- MECNWXGGNCJFQJ-UHFFFAOYSA-N 3-piperidin-1-ylpropane-1,2-diol Chemical compound OCC(O)CN1CCCCC1 MECNWXGGNCJFQJ-UHFFFAOYSA-N 0.000 description 1
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- UMHJEEQLYBKSAN-UHFFFAOYSA-N Adipaldehyde Chemical compound O=CCCCCC=O UMHJEEQLYBKSAN-UHFFFAOYSA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002085 Dialdehyde starch Polymers 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 229920001744 Polyaldehyde Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229930183415 Suberin Natural products 0.000 description 1
- PCSMJKASWLYICJ-UHFFFAOYSA-N Succinic aldehyde Chemical compound O=CCCC=O PCSMJKASWLYICJ-UHFFFAOYSA-N 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GKXVJHDEWHKBFH-UHFFFAOYSA-N [2-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=CC=C1CN GKXVJHDEWHKBFH-UHFFFAOYSA-N 0.000 description 1
- LIQLLTGUOSHGKY-UHFFFAOYSA-N [B].[F] Chemical compound [B].[F] LIQLLTGUOSHGKY-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- PWAXUOGZOSVGBO-UHFFFAOYSA-N adipoyl chloride Chemical compound ClC(=O)CCCCC(Cl)=O PWAXUOGZOSVGBO-UHFFFAOYSA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- LHIJANUOQQMGNT-UHFFFAOYSA-N aminoethylethanolamine Chemical compound NCCNCCO LHIJANUOQQMGNT-UHFFFAOYSA-N 0.000 description 1
- IMUDHTPIFIBORV-UHFFFAOYSA-N aminoethylpiperazine Chemical compound NCCN1CCNCC1 IMUDHTPIFIBORV-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- IZALUMVGBVKPJD-UHFFFAOYSA-N benzene-1,3-dicarbaldehyde Chemical compound O=CC1=CC=CC(C=O)=C1 IZALUMVGBVKPJD-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- RGTXVXDNHPWPHH-UHFFFAOYSA-N butane-1,3-diamine Chemical compound CC(N)CCN RGTXVXDNHPWPHH-UHFFFAOYSA-N 0.000 description 1
- GHWVXCQZPNWFRO-UHFFFAOYSA-N butane-2,3-diamine Chemical compound CC(N)C(C)N GHWVXCQZPNWFRO-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920003174 cellulose-based polymer Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- YQLZOAVZWJBZSY-UHFFFAOYSA-N decane-1,10-diamine Chemical compound NCCCCCCCCCCN YQLZOAVZWJBZSY-UHFFFAOYSA-N 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- HTDKEJXHILZNPP-UHFFFAOYSA-N dioctyl hydrogen phosphate Chemical compound CCCCCCCCOP(O)(=O)OCCCCCCCC HTDKEJXHILZNPP-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- KNVWWMVPZMGMPG-UHFFFAOYSA-N formaldehyde;3-methylbutan-2-one Chemical compound O=C.CC(C)C(C)=O KNVWWMVPZMGMPG-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- LADVLFVCTCHOAI-UHFFFAOYSA-N isocyanic acid;toluene Chemical compound N=C=O.CC1=CC=CC=C1 LADVLFVCTCHOAI-UHFFFAOYSA-N 0.000 description 1
- 229920006276 ketonic resin Polymers 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- JGEMYUOFGVHXKV-UPHRSURJSA-N malealdehyde Chemical compound O=C\C=C/C=O JGEMYUOFGVHXKV-UPHRSURJSA-N 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- KYCGURZGBKFEQB-UHFFFAOYSA-N n',n'-dibutylpropane-1,3-diamine Chemical compound CCCCN(CCCC)CCCN KYCGURZGBKFEQB-UHFFFAOYSA-N 0.000 description 1
- QOHMWDJIBGVPIF-UHFFFAOYSA-N n',n'-diethylpropane-1,3-diamine Chemical compound CCN(CC)CCCN QOHMWDJIBGVPIF-UHFFFAOYSA-N 0.000 description 1
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 1
- ZUXUNWLVIWKEHB-UHFFFAOYSA-N n',n'-dimethylhexane-1,6-diamine Chemical compound CN(C)CCCCCCN ZUXUNWLVIWKEHB-UHFFFAOYSA-N 0.000 description 1
- KMBPCQSCMCEPMU-UHFFFAOYSA-N n'-(3-aminopropyl)-n'-methylpropane-1,3-diamine Chemical compound NCCCN(C)CCCN KMBPCQSCMCEPMU-UHFFFAOYSA-N 0.000 description 1
- IMENJLNZKOMSMC-UHFFFAOYSA-N n'-[2-[2-[2-[2-[2-(2-aminoethylamino)ethylamino]ethylamino]ethylamino]ethylamino]ethyl]ethane-1,2-diamine Chemical compound NCCNCCNCCNCCNCCNCCNCCN IMENJLNZKOMSMC-UHFFFAOYSA-N 0.000 description 1
- QHJABUZHRJTCAR-UHFFFAOYSA-N n'-methylpropane-1,3-diamine Chemical compound CNCCCN QHJABUZHRJTCAR-UHFFFAOYSA-N 0.000 description 1
- HDCAZTXEZQWTIJ-UHFFFAOYSA-N n,n',n'-triethylethane-1,2-diamine Chemical compound CCNCCN(CC)CC HDCAZTXEZQWTIJ-UHFFFAOYSA-N 0.000 description 1
- PZMRMZQWGOESGV-UHFFFAOYSA-N n-ethyl-2-ethyliminoethanamine Chemical compound CCNCC=NCC PZMRMZQWGOESGV-UHFFFAOYSA-N 0.000 description 1
- HALVJFMEOOBLMQ-UHFFFAOYSA-N n-ethyl-2-methyliminoethanamine Chemical compound CCNCC=NC HALVJFMEOOBLMQ-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- SXJVFQLYZSNZBT-UHFFFAOYSA-N nonane-1,9-diamine Chemical compound NCCCCCCCCCN SXJVFQLYZSNZBT-UHFFFAOYSA-N 0.000 description 1
- 229920002601 oligoester Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- NEOPYIBVKJWHMN-UHFFFAOYSA-N pent-2-enedial Chemical compound O=CCC=CC=O NEOPYIBVKJWHMN-UHFFFAOYSA-N 0.000 description 1
- JGQDLMSXMOGEMC-UHFFFAOYSA-N pentane-2,4-diamine Chemical compound CC(N)CC(C)N JGQDLMSXMOGEMC-UHFFFAOYSA-N 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920002454 poly(glycidyl methacrylate) polymer Polymers 0.000 description 1
- 229920000141 poly(maleic anhydride) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- PZZICILSCNDOKK-UHFFFAOYSA-N propane-1,2,3-triamine Chemical compound NCC(N)CN PZZICILSCNDOKK-UHFFFAOYSA-N 0.000 description 1
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001273 sulfonato group Chemical class [O-]S(*)(=O)=O 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- KUCOHFSKRZZVRO-UHFFFAOYSA-N terephthalaldehyde Chemical compound O=CC1=CC=C(C=O)C=C1 KUCOHFSKRZZVRO-UHFFFAOYSA-N 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- FAGUFWYHJQFNRV-UHFFFAOYSA-N tetraethylenepentamine Chemical compound NCCNCCNCCNCCN FAGUFWYHJQFNRV-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 1
- KLNPWTHGTVSSEU-UHFFFAOYSA-N undecane-1,11-diamine Chemical compound NCCCCCCCCCCCN KLNPWTHGTVSSEU-UHFFFAOYSA-N 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、表面に潤滑性樹脂
被覆を有する医療用具に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a medical device having a surface coated with a lubricating resin.
【0002】[0002]
【従来の技術】気道、気管、消化管、尿道、血管、その
他の体腔あるいは組織中に挿入されるカテーテル等の医
療用器具、さらにはこれらに挿入されて体内に挿入され
るガイドワイヤー、スタイレット等の各種医療用具は、
組織を損傷させず、また目的部位まで確実に挿入するこ
とを可能とする円滑性が要求され、さらには組織内に留
置している間に摩擦によって粘膜を損傷したり、炎症を
引き起こしたりすることを避けるために、表面にすぐれ
た潤滑性を有することが要求される。このような要求を
満足するため、体内に挿入する医療器具の基材表面全体
に、無水マレイン酸系高分子物質等の水溶性高分子を共
有結合させて、潤滑性樹脂の被覆を形成することが知ら
れている(特開昭59−81341号、特開平1−195863号、特
公平1−33181号)。2. Description of the Related Art Medical devices such as catheters inserted into the respiratory tract, trachea, digestive tract, urethra, blood vessels, and other body cavities or tissues, and guidewires and stylets inserted into these and inserted into the body. Various medical tools such as
Smoothness is required that does not damage the tissue and ensures that it can be inserted to the target site.Furthermore, it may damage the mucous membrane or cause inflammation due to friction while placed in the tissue In order to avoid this, it is required that the surface has excellent lubricity. In order to satisfy such a demand, a water-soluble polymer such as a maleic anhydride-based polymer substance is covalently bonded to the entire surface of the base material of a medical device to be inserted into the body to form a coating of a lubricating resin. (JP-A-59-81341, JP-A-1-195863, and JP-B-1-33181) are known.
【0003】しかしながら、これら従来技術のように基
材の全表面に被覆を形成すると、体内での摩擦抵抗が小
さくなるとともに、体外の基端部操作部分の摩擦抵抗も
小さくなるため、術者の手が滑りやすくなり、操作性が
低下する。このため、術者は操作部分が濡れないように
注意したり、あるいは特開平3-82478号公報に示される
ような操作用の特殊なアダプターを用いたりする必要が
あった。However, when a coating is formed on the entire surface of the base material as in these conventional techniques, the frictional resistance inside the body is reduced, and the frictional resistance at the operation portion at the proximal end outside the body is also reduced. The hand becomes slippery and the operability decreases. For this reason, the surgeon has to be careful not to wet the operation part or to use a special adapter for operation as disclosed in JP-A-3-82478.
【0004】また、これらの問題を鑑みて、ガイドワイ
ヤにおいて手元側に潤滑性樹脂被覆を行わないもの(特
公平4-45189号)や手元部分に潤滑性をなくす処理を施
したもの(特公平7-83761号)が考えられているが、潤
滑性の無い部分を長く取るとカテーテル導入時や抜去時
にガイドワイヤの潤滑性のない部分がカテーテルの中で
高い摩擦抵抗を発生し、また潤滑性の無い部分を手元側
の短い部分のみにすると術者が潤滑性のある部分に触れ
る機会が増え、操作性をおとすという欠点があった。In view of these problems, a guide wire having no lubricating resin coating on the proximal side (Japanese Patent Publication No. 4-45189) and a guide wire having a lubricity-eliminating treatment applied thereto (Japanese Patent Publication No. Hei 4-45189). No. 7-83761), but if the non-lubricating part is taken longer, the non-lubricating part of the guide wire will generate high frictional resistance in the catheter when introducing or removing the catheter, If only the short portion on the hand side is used for the portion without the gap, the operator has more chances to touch the lubricating portion, and there is a drawback that the operability is reduced.
【0005】[0005]
【発明が解決しようとする課題】本発明は、上述した従
来の技術の欠点を克服することを目的とし、更に体内挿
入時の摺動抵抗を低減減少し、かつその摺動性を損なう
ことなく、操作性を向上させた医療用具を提供すること
を目的とする。SUMMARY OF THE INVENTION An object of the present invention is to overcome the above-mentioned drawbacks of the prior art, and to further reduce and reduce the sliding resistance upon insertion into the body and without impairing the sliding performance. Another object of the present invention is to provide a medical device with improved operability.
【0006】[0006]
【課題を解決するための手段】このような目的は、下記
(1)〜(13)の本発明によって達成される。This and other objects are achieved by the present invention which is defined below as (1) to (13).
【0007】(1)湿潤時に潤滑性を有する潤滑性樹脂
被覆を有する体腔内挿入用の医療用具において、該潤滑
性樹脂被覆の該医療用具上における基端側と先端側とは
摩擦抵抗が異なることを特徴とする医療用具。(1) In a medical device for insertion into a body cavity having a lubricating resin coating having lubricity when wet, a frictional resistance between the base end side and the distal end side of the lubricating resin coating on the medical device is different. A medical device characterized by that:
【0008】(2)前記潤滑性樹脂被覆は前記医療用具
の全体を被覆してなることを特徴とする(1)記載の医
療用具。(2) The medical device according to (1), wherein the lubricating resin coating covers the entire medical device.
【0009】(3)前記潤滑性樹脂被覆は前記先端側の
方が基端側より高密度で被覆されている事を特徴とする
(1)に記載の医療用具。(3) The medical device according to (1), wherein the lubricating resin coating is coated at a higher density on the distal end side than on the base end side.
【0010】(4)前記潤滑性樹脂被覆は基端側から先
端側にかけて3段階以上の段階的に摩擦抵抗が小さくな
ることを特徴とする(1)に記載の医療用具。(4) The medical device according to (1), wherein the frictional resistance of the lubricating resin coating is reduced in three or more steps from the base end to the tip end.
【0011】(5)前記潤滑性樹脂被覆の基端側の摩擦
抵抗が前記潤滑性樹脂被覆を有さない前記医療用具表面
の摩擦抵抗より小さいことを特徴とする(1)に記載の
医療用具。(5) The medical device according to (1), wherein a frictional resistance at a base end side of the lubricating resin coating is smaller than a frictional resistance of a surface of the medical device not having the lubricating resin coating. .
【0012】(6)前記潤滑性樹脂被覆の基端側の摩擦
抵抗が、先端側の摩擦抵抗の1.2倍以上かつ20倍未
満の大きさであることを特徴とする(5)に記載の医療
用具。(6) The frictional resistance at the base end of the lubricating resin coating is 1.2 times or more and less than 20 times the frictional resistance at the tip end of the lubricating resin coating. Medical tools.
【0013】(7)前記樹脂被覆は、水溶性高分子物質
またはその誘導体を含む上記(1)に記載の医療用具。(7) The medical device according to the above (1), wherein the resin coating contains a water-soluble polymer substance or a derivative thereof.
【0014】(8)前記水溶性高分子物質は、無水マレ
イン酸系高分子物質である上記(7)に記載の医療用
具。(8) The medical device according to (7), wherein the water-soluble polymer is a maleic anhydride-based polymer.
【0015】(9)前記水溶性高分子物質は、基材表面
に存在する反応性官能基と共有結合している上記(1)
〜(8)のいずれかに記載の医療用具。(9) The water-soluble polymer substance is covalently bonded to a reactive functional group present on the surface of the substrate.
The medical device according to any one of (1) to (8).
【0016】(10)上記樹脂被覆は、水溶性または水
膨潤性重合体の架橋物または高分子化合物が、医療用具
の基材表面で、相互貫入網目構造を形成する上記(1)
に記載の医療用具。(10) In the above resin coating, a crosslinked product or a high molecular compound of a water-soluble or water-swellable polymer forms an interpenetrating network structure on the surface of a substrate of a medical device.
A medical device according to claim 1.
【0017】(11)該重合体がエポキシ基を有するブ
ロックポリマーである上記(1)に記載の医療用具。(11) The medical device according to the above (1), wherein the polymer is a block polymer having an epoxy group.
【0018】(12)該重合体がマクロモノマーである
上記(1)に記載の医療用具。(12) The medical device according to the above (1), wherein the polymer is a macromonomer.
【0019】(13)水溶性または水膨潤性重合体を医
療用具の基材が膨潤する溶媒に溶解して該重合体溶液を
作製し、該溶液に医療用具の基材を浸漬して膨潤させ、
さらに基材表面で該重合体を架橋または高分子化させた
上記(1)に記載の医療用具。(13) A polymer solution is prepared by dissolving a water-soluble or water-swellable polymer in a solvent that swells the base of a medical device, and immersed in the solution to swell the base of the medical device. ,
The medical device according to the above (1), wherein the polymer is further crosslinked or polymerized on the substrate surface.
【0020】[0020]
【発明の実施の形態】以下、本発明の具体的構成につい
て詳細に説明する。BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, a specific configuration of the present invention will be described in detail.
【0021】本発明の医療用具の潤滑性の樹脂被覆を形
成するのに用いる水溶性高分子物質は、医療用具基材上
に共有結合により固定されることが好ましい。このよう
な水溶性高分子物質は、原則として鎖状で架橋のない高
分子が−OH,−CONH2,−COOH,−NH2,−COO-,−SO3 -,
−NR3 +などの親水基をもつもので、具体的に天然水溶性
高分子としては、カルボキシルメチルデンプン、ジアル
デヒドデンプン等のデンプン系、カルボキシメチルセル
ロース等のセルロース系、タンニン、ニグニン系、アル
ギン酸、アラビアゴム、グアーガム、トラガントガム、
タマリント種、キチン、キトサン等の多糖類系、ゼラチ
ン、カゼイン、にかわ、コラーゲン合成水溶性高分子等
のタンパク質等が考えられる。合成水溶性高分子物質と
しては、ポリビニルアルコールや、ポリエチレンオキサ
イド、ポリエチレングリコール等のポリエチレンオキサ
イド系、ポリアクリル酸ソーダ等のアクリル酸系、メチ
ルビニルエーテル無水マレイン酸共重合体等の無水マレ
イン酸系、ポリヒドロキシエチルフタル酸エステル等の
フタル酸系、ポリジメチルロールプロピオン酸エステル
等の水溶性ポリエステル、メチルイソプロピルケトンホ
ルムアルデヒド樹脂等のケトンアルデヒド樹脂、ポリア
クリルアミド等のアクリルアミド系、ポリビニルピロリ
ドン、ポリアミン、ポリ電解質、水溶性ナイロン等が考
えられる。これらのうちでは、特に無水マレイン酸系高
分子物質、セルロース系高分子物質、ポリエチレンオキ
サイド系高分子物質、水溶性ナイロンが湿潤時の潤滑性
およびその持続性が高いため好ましい。The water-soluble polymer substance used for forming the lubricating resin coating of the medical device of the present invention is preferably fixed on the medical device substrate by covalent bonding. Such water-soluble polymer are in principle no crosslinking a chain-like as the polymer is -OH, -CONH 2, -COOH, -NH 2, -COO -, -SO 3 -,
-NR 3 + those having a hydrophilic group such as the specific natural water-soluble polymers, carboxymethyl starch, starch such as dialdehyde starch-based, cellulose-based, such as carboxymethyl cellulose, tannin, Nigunin system, alginic acid, Gum arabic, guar gum, tragacanth gum,
Tamarind species, polysaccharides such as chitin and chitosan, gelatin, casein, glue, and proteins such as collagen synthetic water-soluble polymers are conceivable. Synthetic water-soluble polymer substances include polyvinyl alcohol, polyethylene oxides such as polyethylene oxide and polyethylene glycol, acrylics such as sodium polyacrylate, maleic anhydrides such as methyl vinyl ether maleic anhydride copolymer, Phthalic acid such as hydroxyethyl phthalate; water-soluble polyester such as polydimethyllol propionate; ketone aldehyde resin such as methyl isopropyl ketone formaldehyde resin; acrylamide such as polyacrylamide; polyvinylpyrrolidone; polyamine; polyelectrolyte; Nylon and the like are conceivable. Among these, maleic anhydride-based polymer substances, cellulose-based polymer substances, polyethylene oxide-based polymer substances, and water-soluble nylon are particularly preferred because of their high lubricity when wet and their sustainability.
【0022】そして、このような効果は、特に無水マレ
イン酸系高分子物質を用いたとき、きわめて高いものと
なる。この場合、無水マレイン酸系高分子物質としては
無水マレイン酸のホモポリマーであっても、コポリマー
であってもよい。これらの中では、特に、メチルビニル
エーテル無水マレイン酸共重合体が好適である。このよ
うなものとしては、G.A.F.コーポレーションからGANTRE
Z AN(商品名)として市販されているほぼ1:1の共重合
体が挙げられる。Such effects are extremely high especially when a maleic anhydride-based polymer is used. In this case, the maleic anhydride-based polymer substance may be a maleic anhydride homopolymer or a copolymer. Among these, a methyl vinyl ether maleic anhydride copolymer is particularly preferred. Some of these include GANTRE from GAF Corporation.
An approximately 1: 1 copolymer commercially available as ZAN (trade name) may be mentioned.
【0023】また、その誘導体とは水溶性に限定され
ず、上記水溶性高分子物質を基本構成としていれば、特
に制限はなく、不溶化されたものについても後述の如く
分子鎖に自由度があり、かつ含水するものであればよ
い。例えば、上記水溶性高分子物質の縮合、付加、置
換、酸化、還元反応などで得られるエステル化物、塩、
アミド化物、無水物、ハロゲン化物、エーテル化物、加
水分解物、アセタール化物、ホルマール化物、アルキロ
ール化物、4級化物、ジアゾ化物、ヒドラジド化物、ス
ルホン化物、ニトロ化物、イオンコンプレックス;ジア
ゾニウム基、アジド基、イソシアネート基、酸クロリド
基、酸無水物基、イミノ炭酸エステル基、アミノ基、カ
ルボキシル基、エポキシ基、水酸基、アルデヒド基等、
反応性官能基を2個以上有する物質との架橋物;ビニル
化合物、アクリル酸、メタクリル酸、ジエン系化合物、
無水マレイン酸等との共重合物などがある。The derivative is not limited to water-soluble, and is not particularly limited as long as the above-mentioned water-soluble polymer is used as a basic structure. What is necessary is just a thing which contains water. For example, esterification products, salts obtained by condensation, addition, substitution, oxidation, reduction reaction and the like of the water-soluble polymer substance,
Amidates, anhydrides, halides, ethers, hydrolysates, acetalates, formalides, alkylolates, quaternaries, diazoides, hydrazides, sulfonates, nitrates, ion complexes; diazonium groups, azide groups , Isocyanate group, acid chloride group, acid anhydride group, imino carbonate group, amino group, carboxyl group, epoxy group, hydroxyl group, aldehyde group, etc.
Crosslinked product with a substance having two or more reactive functional groups; vinyl compound, acrylic acid, methacrylic acid, diene compound,
There are copolymers with maleic anhydride and the like.
【0024】このような水溶性高分子物質は、水によく
溶解し、その溶液をある物体間に存在せしめると、両者
間の摩擦抵抗を著しく低下させることができ、潤滑剤と
して用いることができる。また、これらの水溶性高分子
物質の縮合または付加反応や置換反応などで得られる誘
導体や、一部架橋などにされたものも潤滑剤として効果
的である。これらを基材中もしくは基材表面に存在また
は導入された反応性官能基と共有結合させることによ
り、基材上に担持された潤滑層を得ることが可能とな
り、水に溶けることなく持続的な潤滑性表面を得ること
ができる。これら水溶性高分子物質の平均分子量は、特
に制限はないが、1〜500万程度のものが潤滑性も高
く、適度な厚さに、しかも含水時における膨潤度も著し
く大きくない潤滑層が得られ好適である。Such a water-soluble polymer substance is well dissolved in water, and when the solution is allowed to exist between certain objects, the frictional resistance between the two can be significantly reduced, and can be used as a lubricant. . In addition, derivatives obtained by condensation or addition reaction or substitution reaction of these water-soluble polymer substances, and those partially cross-linked or the like are also effective as lubricants. By covalently bonding these to a reactive functional group present or introduced in the substrate or on the substrate surface, it is possible to obtain a lubricating layer supported on the substrate, and to provide a sustainable A lubricious surface can be obtained. The average molecular weight of these water-soluble polymer substances is not particularly limited, but those having about 1 to 5,000,000 have high lubricity, have an appropriate thickness, and have a lubricating layer which does not have a remarkably large swelling degree when containing water. It is preferred.
【0025】基材中もしくは基材表面上に、存在または
導入される反応性官能基は、前記水溶性高分子物質と反
応し、結合ないし架橋して固定するものであれば、特に
制限はないが、ジアゾニウム基、アジド基、イソシアネ
ート基、酸クロリド基、酸無水物基、イミノ炭酸エステ
ル基、アミノ基、カルボキシル基、エポキシ基、水酸
基、アルデヒド基等が考えられ、特にイソシアネート
基、アミノ基、アルデヒド基、エポキシ基が好適であ
る。反応性官能基含有基材としては、ポリウレタン、ポ
リアミドなどが好適である。The reactive functional group present or introduced into the substrate or on the substrate surface is not particularly limited as long as it reacts with the above-mentioned water-soluble polymer substance and bonds or cross-links it to fix it. Is, diazonium group, azide group, isocyanate group, acid chloride group, acid anhydride group, imino carbonate group, amino group, carboxyl group, epoxy group, hydroxyl group, aldehyde group, etc., especially isocyanate group, amino group, Aldehyde groups and epoxy groups are preferred. Polyurethane, polyamide and the like are suitable as the reactive functional group-containing substrate.
【0026】また、各種医療用具の外壁、内壁などを構
成する基材としては、通常、これら反応性官能基を含有
していないものも用いられる。このようなときには前述
のように反応性官能基を有する物質にて処理し、反応性
官能基を基材に存在させ、この上に水溶性高分子物質を
共有結合させる。結合形態は、共有結合、イオン結合、
物理的付着など種々あるが、持続性に点を考慮すると、
共有結合が最も好ましい。このような反応性官能基を有
する物質としては、例えば、エチレンジイソシアネー
ト、ヘキサメチレンジイソシアネート、キシレンジイソ
シアネート、トルエンジイソシアネート、ジフェニルメ
タンジイソシアネート、ナフタレンジイソシアネート、
ジフェニルメタンジイソシアネート、フェニレンジイソ
シアネート、シクロヘキシレンジイソシアネート、トル
フェニルメタントリイソシアネート、トルエントリイソ
シアネートなどのポリイソシアネート、およびこれらポ
リイソシアネートとポリオールのアダクトまたはプレポ
リマー等や、さらに、例えば低分子ポリアミンとしてエ
チレンジアミン、トリメチレンジアミン、1,2−ジアミ
ノプロパン、テトラメチレンジアミン、1,3−ジアミノ
ブタン、2,3−ジアミノブタン、ペンタメチレンジアミ
ン、2,4−ジアミノペンタン、ヘキサメチレンジアミ
ン、オクタメチレンジアミン、ノナメチレンジアミン、
デカメチレンジアミン、ウンデカメチレンジアミン、デ
ドカメチレンジアミン、トリデカメチレンジアミン、オ
クタデカメチレンジアシン、N,N−ジメチルエチレンジ
アミン、,N−ジエチルトリメチレンジアミン、N,N−ジ
メチルトリメチレンジアミン、N,N−ジブチルトリメチ
レンジアミン、N,N,N′−トリエチルエチレンジアミ
ン、N−メチルトリメチレンジアミン、N−N−ジメチ
ル−p−フェニレンジアミン、N,N−ジメチルヘキサメ
チレンジアミン、ジエチレントリアミン、トリエチレン
テトラミン、テトラエチレンペンタミン、ヘプタエチレ
ンオクタミン、ノナエチレンデカミン、1,3−ビス
(2′−アミノエチルアミノ)プロパン、ビス(3−ダ
ミノプロパル)アミン、N1,3−ビス(3′−アシノプロ
ピルアミノ)プロパン、1,2,3−トリアミノプロパン、
トリス(2−アミノエチル)アミン、テトラ(アミノメ
チル)メタン、メチルイミノビスプロピルアミン、メチ
ルイミノビスエチルアミン、エチルイミノビスエチルア
ミン、N−アミノプロピル−2−モルホリン、N−アミ
ノプリピル−2−ピペコリン、N−(2−ヒドロキシエ
チル)トリメチレンジアミン、キシリレンジアミン、フ
ェニレンジアミン、ピペラジン、N−メチルピペラジ
ン、N−(2−アミノエチル)エタノールアミン、N−
アミノエチルピペラジン、N,N,N′N′−テトラメチル
エチレンジアミン、N,N,N′N′−テトラメチルテトラ
メチレンジアミンなどが挙げられ、高分子ポリアミンと
して〔I〕アミンとアルキレンジハライドあるいはエピ
クロルヒドリンから合成されるポリ(アルキレンポリア
ミン)〔エンサイクロピディア・オブ・ポリマー・サイ
エンス・アンド・テクノロジー(Encyclopedia of Poly
mer Science and Technology)10巻、616ページ〕、〔I
I〕エチレンイミン、プロピレンイミンなどのアルキレ
ンイミンの開環重合によって得られるアルキレンイミン
重合体〔エンサウクロピディア・オブ・ポリマー・サイ
エンス・アンド・テクノロジー、1巻、734ページ〕、
〔III〕その他、ポリビニルアミン、ポリリジンなどの
ポリアミン、さらに、グルタルアルデヒド、テレフタル
アルデヒド、イソフタルアルデヒド、ジアルデヒド、で
んぷん、ガリオキサール、マロンアルデヒド、コハク酸
アルドヒド、アジプアルデヒド、ピメリンジアルデヒ
ド、スベリンジアルデヒド、マレインアルデヒド、2−
ペンテン−1,5−ジアルデヒドなどのポリアルデヒド、
さらにエチレングリコールジグリシジルエーテル、ポリ
エチレングリコールジグリシジルエーテル、プロピレン
グリコールジグリンジルエーテル、ポリプロピレンジグ
リンシジルエーテル、ヘキサンジオールジグリシジルエ
ーテル、トリメチエロールプロパントリグリシジルエー
テルなどのポリエポキシドがある。なお、これらのうち
では特に4,4′−ジフェニルメタンジイソシアネート、
トリレンジイソシアネートとトリメチロールプロパンと
のアダクト(付加体)、ヘキサメチレンジイソシアネー
トとトリメチロールプロパンとのアダクト、あるいはそ
のトリマー、ジエチレントリアミンが最も好ましい。Further, as the base material constituting the outer wall, the inner wall and the like of various medical devices, those not containing these reactive functional groups are usually used. In such a case, treatment with a substance having a reactive functional group is performed as described above, the reactive functional group is made to exist on the substrate, and a water-soluble polymer substance is covalently bonded thereon. The bonding form is a covalent bond, an ionic bond,
There are various things such as physical adhesion, but considering the point of persistence,
Covalent bonds are most preferred. As the substance having such a reactive functional group, for example, ethylene diisocyanate, hexamethylene diisocyanate, xylene diisocyanate, toluene diisocyanate, diphenylmethane diisocyanate, naphthalene diisocyanate,
Diphenylmethane diisocyanate, phenylene diisocyanate, cyclohexylene diisocyanate, polyisocyanates such as tolphenylmethane triisocyanate, toluene isocyanate, and adducts or prepolymers of these polyisocyanates and polyols. 1,2-diaminopropane, tetramethylenediamine, 1,3-diaminobutane, 2,3-diaminobutane, pentamethylenediamine, 2,4-diaminopentane, hexamethylenediamine, octamethylenediamine, nonamethylenediamine,
Decamethylenediamine, undecamethylenediamine, dedocamethylenediamine, tridecamethylenediamine, octadecamethylenediacin, N, N-dimethylethylenediamine, N-diethyltrimethylenediamine, N, N-dimethyltrimethylenediamine, N , N-dibutyltrimethylenediamine, N, N, N'-triethylethylenediamine, N-methyltrimethylenediamine, NN-dimethyl-p-phenylenediamine, N, N-dimethylhexamethylenediamine, diethylenetriamine, triethylenetetramine , Tetraethylenepentamine, heptaethyleneoctamine, nonaethylenedecamine, 1,3-bis (2'-aminoethylamino) propane, bis (3-daminopropal) amine, N1,3-bis (3'-acinopropyl) Amino) propane, 1,2,3-triamino propane,
Tris (2-aminoethyl) amine, tetra (aminomethyl) methane, methyliminobispropylamine, methyliminobisethylamine, ethyliminobisethylamine, N-aminopropyl-2-morpholine, N-aminopropyl-2-pipecholine, N -(2-hydroxyethyl) trimethylenediamine, xylylenediamine, phenylenediamine, piperazine, N-methylpiperazine, N- (2-aminoethyl) ethanolamine, N-
Aminoethylpiperazine, N, N, N'N'-tetramethylethylenediamine, N, N, N'N'-tetramethyltetramethylenediamine, and the like. Examples of high molecular polyamines are [I] amine and alkylenedihalide or epichlorohydrin. Poly (alkylene polyamine) [Encyclopedia of Polymer Science and Technology
mer Science and Technology) 10, 616 pages], [I
I] ethyleneimine, alkyleneimine polymers obtained by ring-opening polymerization of alkyleneimines such as propyleneimine (Ensauclopidia of Polymer Science and Technology, Vol. 1, p. 734),
[III] In addition, polyamines such as polyvinylamine and polylysine, and further, glutaraldehyde, terephthalaldehyde, isophthalaldehyde, dialdehyde, starch, galloxal, malonaldehyde, succinic aldehyde, adipaldehyde, pimerin dialdehyde, suberin dialdehyde , Malealdehyde, 2-
Polyaldehydes such as pentene-1,5-dialdehyde,
Furthermore, there are polyepoxides such as ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, polypropylene diglincidyl ether, hexanediol diglycidyl ether, and trimethylolpropane triglycidyl ether. Incidentally, among these, 4,4'-diphenylmethane diisocyanate,
An adduct (adduct) of tolylene diisocyanate and trimethylolpropane, an adduct of hexamethylene diisocyanate and trimethylolpropane, or a trimer thereof, and diethylenetriamine are most preferred.
【0027】本発明において、水溶性高分子物質に用い
る基材の材質上の制限はきわめて少ない。従って、用い
る基材としては、例えば、ポリアミド、ポリエステル、
ポリ塩化ビニル、ポリスチレン、ポリアクリル酸エステ
ル、ポリメタクリル酸エステル、ポリアクリロニトリ
ル、ポリアクリルアミド、ポリアクリル酸、ポリメタク
リル酸、ポリエチレン、ポリプロピレン、ポリビニルア
ルコール、ポリ無水マレイン酸、ポリエチレンイミン。
ポリウレタン、ポリ酢酸ビニル、シリコール樹脂、各種
ラテックス、さらにはこれらの各種共重合体、ブレンド
体等の各種有機高分子基材や、ガラス、セラミックス、
ステンレス等の各種無機ないし金属基材のいずれであっ
てもよい。そして、これら基材中には、必要に応じ各種
添加剤が含有されていてもよい。In the present invention, there are very few restrictions on the material of the substrate used for the water-soluble polymer substance. Therefore, as the substrate to be used, for example, polyamide, polyester,
Polyvinyl chloride, polystyrene, polyacrylate, polymethacrylate, polyacrylonitrile, polyacrylamide, polyacrylic acid, polymethacrylic acid, polyethylene, polypropylene, polyvinyl alcohol, polymaleic anhydride, polyethyleneimine.
Polyurethane, polyvinyl acetate, silicone resin, various latexes, and various organic polymer base materials such as various copolymers and blends thereof, glass, ceramics,
Any of various inorganic or metal substrates such as stainless steel may be used. And these base materials may contain various additives as needed.
【0028】なお、基材として、特にその潤滑性持続効
果が高いのは、有機高分子樹脂であり、そのうち、ポリ
塩化ビニル系、ポリウレタン系、ポリアミド系、ラテッ
クス系、ポリエステル系は最もその効果が高い。It is to be noted that organic polymer resins having particularly high lubricating sustaining effect as a base material are polyvinyl chloride-based, polyurethane-based, polyamide-based, latex-based and polyester-based ones, which have the highest effect. high.
【0029】従って、これらの他の樹脂ないし金属、ガ
ラス等を基材とするときには、前述の基材に用いたと同
様の各種有機高分子樹脂からなる層を、予め基材表面に
形成しておき、反応性官能基を導入したり、該樹脂と反
応性官能基を有する物質をブレンドしたりして潤滑層を
設けるとより好ましい結果をうる。Therefore, when these other resins, metals, glass, etc. are used as the base material, layers composed of various organic polymer resins similar to those used for the above-described base material are formed on the surface of the base material in advance. More preferable results can be obtained by providing a lubricating layer by introducing a reactive functional group or blending the resin with a substance having a reactive functional group.
【0030】湿潤時に潤滑性を有する水溶性または水膨
潤性重合体は、要求される機械的強度や潤滑性の機能に
より異なるが、加熱処理や触媒を添加することにより架
橋するエポキシ基を有するブロックポリマーや高分子化
するマクロモノマーが好適に使用される。また、患者の
体温(30〜40℃)において吸水し、潤滑性を発現す
る重合体であり、架橋または不溶化した際に吸水率が1
00%以下のものである。The water-soluble or water-swellable polymer having lubricity when wet differs depending on the required mechanical strength and lubricity function, but has a block having an epoxy group which is crosslinked by heat treatment or addition of a catalyst. A polymer or a macromonomer to be polymerized is preferably used. It is a polymer that absorbs water at the patient's body temperature (30 to 40 ° C.) and exhibits lubricity, and has a water absorption of 1 when crosslinked or insolubilized.
It is less than 00%.
【0031】さらにブロックポリマーにおいては、潤滑
性を発現する部位とエポキシ基を有する部位とからなる
ブロック共重合体であることが望ましい。潤滑性を発現
する部位は、体液や水系溶媒中において潤滑性を発現す
ればいかなるものであっても良いが、合成の容易性や操
作性などを考慮すると、アクリルアミド、アクリルアミ
ド誘導体よりなる重合体、N,N−ジメチルアミノエチ
ルアクリレート、糖、リン脂質を側鎖に有する単量体を
構成成分とする重合体あるいは無水マレイン酸系重合体
などが挙げられる。無水マレイン酸系重合体としては、
水溶解性に限定されず、無水マレイン酸系高分子を主成
分としていれば不溶化されたものであっても、湿潤時に
潤滑性を発現するものであれば良い。さらに、基材を膨
潤させる溶媒に、重合体を溶解させてコーティングする
ことを考慮すると、有機溶媒にも可溶な重合体、すなわ
ち両親媒性重合体が好ましい。Further, the block polymer is desirably a block copolymer comprising a site exhibiting lubricity and a site having an epoxy group. The site exhibiting lubricating properties may be any as long as it exhibits lubricating properties in a body fluid or an aqueous solvent, but in consideration of ease of synthesis or operability, acrylamide, a polymer comprising an acrylamide derivative, Examples thereof include a polymer having a monomer having N, N-dimethylaminoethyl acrylate, a sugar, and a phospholipid in a side chain as a component or a maleic anhydride polymer. As the maleic anhydride polymer,
It is not limited to water solubility, and may be insolubilized as long as it contains a maleic anhydride-based polymer as a main component, as long as it exhibits lubricity when wet. Furthermore, in consideration of dissolving the polymer in a solvent that swells the substrate and coating the polymer, a polymer that is also soluble in an organic solvent, that is, an amphiphilic polymer is preferable.
【0032】一方マクロモノマーにおいては、枝の部分
が潤滑性を発現する部位で、幹の部分が加熱処理により
架橋または高分子化するドメインを有する部位であるこ
とが望ましい。具体的には、グリシジルメタアクリレー
トとジメチルアクリルアミドとのマクロモノマー、グリ
シジルメタアクリレートと無水マレイン酸・ヒドロキシ
エチルメタアクリレート共重合体とのマクロモノマー、
グリシジルメタアクリレートと無水マレイン酸・アクリ
ルアミド共重合体とのマクロモノマー等が例示される。
またその基材は、機械的強度が大きく寸法が著しく変化
しなければ、溶媒に対して膨潤すればいかなるものであ
っても構わないが、好ましくは数1の式により算出され
た膨潤率が、1〜100%、好ましくは5〜40%、よ
り好ましくは10〜30%の条件で該重合体をコーティ
ングできる基材と溶媒の組み合わせであることが望まれ
る。On the other hand, in the macromonomer, it is desirable that the branch portion is a portion exhibiting lubricity and the trunk portion is a portion having a domain which is crosslinked or polymerized by heat treatment. Specifically, a macromonomer of glycidyl methacrylate and dimethylacrylamide, a macromonomer of glycidyl methacrylate and a maleic anhydride / hydroxyethyl methacrylate copolymer,
A macromonomer of glycidyl methacrylate and maleic anhydride / acrylamide copolymer is exemplified.
The base material may be any material as long as it swells with respect to the solvent, as long as the mechanical strength is not significantly changed in size, but preferably, the swelling ratio calculated by the equation 1 is: A combination of a substrate and a solvent that can coat the polymer under the conditions of 1 to 100%, preferably 5 to 40%, more preferably 10 to 30% is desired.
【0033】[0033]
【数1】 (Equation 1)
【0034】また、膨潤率は以下の方法で測定する。The swelling ratio is measured by the following method.
【0035】(1)医療用具を構成する基材を1cm×
3cm×0.3mmのシートに切断し(この時の重量を
Woとする)、溶媒25mlに浸漬させる。(1) The base material constituting the medical device is 1 cm ×
The sheet is cut into a sheet of 3 cm × 0.3 mm (weight at this time is Wo) and immersed in 25 ml of a solvent.
【0036】(2)浸漬後、即座に表面に存在する溶媒
を拭き取り、重量変化(ΔW)を算出する。浸漬時間に
関しては、基材の寸法が著しく変化せず、要求されてい
る物性が保持される範囲内であれば、いかなる時間でも
構わないが、操作性の観点から1秒〜10分、好ましく
は10秒〜5分、より好ましくは30秒〜3分であるこ
とが望まれる。(2) Immediately after immersion, the solvent existing on the surface is wiped off, and the change in weight (ΔW) is calculated. Regarding the immersion time, any time may be used as long as the dimensions of the base material do not significantly change and the required physical properties are maintained, but from the viewpoint of operability, 1 second to 10 minutes, preferably It is desired to be 10 seconds to 5 minutes, more preferably 30 seconds to 3 minutes.
【0037】さらに、具体的な素材としては、ポレオレ
フィン、変性ポレオレフィン、ハロゲン化ポレオレフィ
ン、ポリエーテル、ポリウレタン、ポリアミド、ポリエ
ステル、あるいはこれらのブロックまたはグラフト共重
合体やアロイ化成型物や多層化成形物であり、アルカリ
金属アルコラート基、アミノ基、アルカリ金属アミド
基、カルボン酸基、スルホン酸基、マグネシウムハライ
ド基およびフッ素ホウ素系錯体基を含有する必要はな
く、使用する溶媒に膨潤すれば良い。Further, specific examples of the material include polyolefin, modified polyolefin, halogenated polyolefin, polyether, polyurethane, polyamide, polyester, or a block or graft copolymer thereof, an alloy molded product, or a multilayered product. It is a molded product, and does not need to contain an alkali metal alcoholate group, an amino group, an alkali metal amide group, a carboxylic acid group, a sulfonic acid group, a magnesium halide group and a fluorine-boron complex group, and may swell in the solvent used. .
【0038】本発明における、先端側と基端側とで摩擦
抵抗の異なる潤滑性樹脂被覆を有することを特徴とする
医療用具は、水系の液体にぬれた状態で、挿入時や、摺
動時や、体内留置時等に、低い摩擦抵抗を要求される表
面をもつものである。従って、具体的には、下記のよう
なものがある。The medical device according to the present invention, characterized in that it has a lubricating resin coating having different frictional resistance between the distal end side and the proximal end side, when inserted or slid when wet with an aqueous liquid. Also, it has a surface that requires low frictional resistance when placed in the body. Therefore, there are concretely the following.
【0039】1)胃管カテーテル、栄養カテーテル、ED
(経管栄養用)チューブ、内視鏡などの経口ないし経鼻
的に消化管内に挿入ないし留置されるカテーテル類およ
びこれらのためのガイドワイヤ。1) Gastric catheter, feeding catheter, ED
Catheters that are inserted or placed in the digestive tract orally or nasally, such as tubes and endoscopes (for tube feeding), and guidewires therefor.
【0040】2)酸素カテーテル、酸素カヌラ、気管内
チューブのチューブやカフ、気管切開チューブのチュー
ブやカフ、気管内吸引カテーテルなどの経口ないし経鼻
的に気道ないし気管内に挿入ないし留置されるカテーテ
ル類。2) Oxygen catheter, oxygen cannula, endotracheal tube tube and cuff, tracheostomy tube tube and cuff, intratracheal suction catheter, and other oral or nasal catheters inserted or placed in the airway or trachea. Kind.
【0041】3)尿道カテーテル、導尿カテーテル、バ
ルーンカテーテルのカテーテルやバルーンなどの尿道な
いし尿管挿入ないし留置用のカテーテル類の外表面。3) Outer surfaces of urethral or ureteral insertion or indwelling catheters such as urinary catheters, urinary catheters, balloon catheters and balloons.
【0042】4)吸引カテーテル、排液カテーテル、直
腸カテーテルなど各種体腔ないし組織内挿入ないし留置
用のカテーテル類。4) Catheters for insertion or placement in various body cavities or tissues, such as suction catheters, drainage catheters, and rectal catheters.
【0043】5)留置針、IVHカテーテル、サーモダイ
リューションカテーテル、血管造影カテーテル、PTCA用
カテーテルダイレーター、イントロデューサー、血管用
超音波プローブなどの血管内挿入ないし留置用のカテー
テル類。あるいは、これらカテーテル用のガイドワイ
ヤ、スタイレット等の外表面。5) Intravascular insertion or indwelling catheters such as indwelling needles, IVH catheters, thermodilution catheters, angiographic catheters, PTCA catheter dilators, introducers, and vascular ultrasonic probes. Alternatively, the outer surface of a guidewire, stylet, etc. for these catheters.
【0044】6)各種器管内挿入用内視鏡の外表面など
挿入時、摺動時または体内留置時等低い摩擦抵抗を要求
される医療用具の表面。6) The surface of a medical device such as an outer surface of an endoscope for insertion into various organs, which requires low frictional resistance when inserted, slid or placed inside the body.
【0045】[0045]
【実施例】以下に、本発明の実施例を示し、本発明をさ
らに詳細に説明する。前記のとおり、体内に挿入し、目
的部位まで移動操作する代表的な医療用具の代表例とし
ては、カテーテル、またカテーテルの案内用としてガイ
ドワイヤがある。ここではガイドワイヤを例として挙
げ、本発明の効果を例証する。The present invention will be described below in more detail with reference to Examples of the present invention. As described above, a typical example of a typical medical device that is inserted into the body and moved to a target site is a catheter and a guidewire for guiding the catheter. Here, the effect of the present invention is illustrated by taking a guide wire as an example.
【0046】樹脂被覆は以下のように形成した。アジピ
ン酸2塩化物72.3gに50℃でトリエチレングリコ
ール29.7gを滴下した後、50℃で3時間塩酸を減
圧除去して得られたオリゴエステル22.5gにメチル
エチルケトン4.5gを加え水酸化ナトリウム5g、3
1%過酸化水素6.93g、界面活性剤ジオクチルフォ
スフェート0.44g、水120gよりなる溶液に滴下
し、−5℃で20分間反応させた。反応生成物を水洗、
メタノール洗浄を繰り返した後、乾燥させて分子内に複
数のパーオキサイド基を有するポリ過酸化物を得た。こ
のポリ過酸化物を開始剤として0.5g、グリシジルメ
タクリレート(GMA)9.5gを、ベンゼン30gを
溶媒として、80℃、2時間減圧下で撹拌しながら重合
した。反応生成物は貧溶媒をジエチルエーテル、良溶媒
をテトラヒドロフランとして精製し、分子内に複数のパ
ーオキサイド基を有するポリグリシジルメタアクリレー
ト(PPO−GMA)を得た。続いてPPO−GMA
1.0gをジメチルアクリルアミド9.0g、溶媒とし
てジメチルスルフォキシド90gを仕込み、減圧で密閉
にした後、80℃に加熱して18時間重合反応を行なっ
た。反応後、貧溶媒をジエチルエーテル、良溶媒をテト
ラヒドロフランとして精製し、分子内にエポキシ基材を
有する湿潤時に潤滑性を発現するブロックポリマーを得
た。本ポリマーはNMRおよびIR測定により、分子内
にエポキシ基の存在が確認できた。The resin coating was formed as follows. To 72.3 g of adipic acid dichloride, 29.7 g of triethylene glycol was added dropwise at 50 ° C., and hydrochloric acid was removed under reduced pressure at 50 ° C. for 3 hours. To 22.5 g of the obtained oligoester, 4.5 g of methyl ethyl ketone was added, and water was added. 5 g of sodium oxide, 3
The solution was dropped into a solution consisting of 6.93 g of 1% hydrogen peroxide, 0.44 g of surfactant dioctyl phosphate and 120 g of water, and reacted at -5 ° C for 20 minutes. Washing the reaction product with water,
After repeating the methanol washing, drying was performed to obtain a polyperoxide having a plurality of peroxide groups in the molecule. 0.5 g of this polyperoxide as an initiator and 9.5 g of glycidyl methacrylate (GMA) were polymerized in 30 g of benzene with stirring at 80 ° C. for 2 hours under reduced pressure. The reaction product was purified using diethyl ether as the poor solvent and tetrahydrofuran as the good solvent to obtain polyglycidyl methacrylate (PPO-GMA) having a plurality of peroxide groups in the molecule. Then PPO-GMA
1.0 g of dimethylacrylamide (9.0 g) and dimethylsulfoxide (90 g) as a solvent were charged and sealed under reduced pressure, and then heated to 80 ° C. to perform a polymerization reaction for 18 hours. After the reaction, purification was performed using diethyl ether as the poor solvent and tetrahydrofuran as the good solvent to obtain a block polymer having an epoxy substrate in the molecule and exhibiting lubricity when wet. NMR and IR measurements of this polymer confirmed the presence of an epoxy group in the molecule.
【0047】上記ブロックポリマーを重量比で2%、ク
ロロホルムに溶解させ、ピリジンを適量加えたものに、
外径0.6mmのNi−Ti製芯金に熱可塑性ポリウレタン樹脂
をコートし外径0.89mmとしたガイドワイヤを数秒浸漬さ
せ、常温乾燥させた。さらにコーティングしたガイドワ
イヤを60〜100℃で加熱乾燥して、全面を潤滑性処理し
たガイドワイヤを得た。また、上記ブロックポリマーの
溶液中に溶解させたブロックポリマーの重量比2%のも
のに対し、1.5%・1%・0.5%・0.4%・0.3%・0.16%
・0.08%のブロックポリマー溶解液それぞれによって、
全面を同様な方法でコートしたガイドワイヤを作製し
た。The above block polymer was dissolved in chloroform at a weight ratio of 2%, and an appropriate amount of pyridine was added to the solution.
A guide wire having an outer diameter of 0.89 mm was immersed for several seconds by coating a thermoplastic polyurethane resin on a Ni-Ti core metal having an outer diameter of 0.6 mm, and dried at room temperature. Further, the coated guide wire was dried by heating at 60 to 100 ° C. to obtain a guide wire whose entire surface was lubricated. In addition, 1.5%, 1%, 0.5%, 0.4%, 0.3%, 0.16% of the block polymer dissolved in the block polymer solution at a weight ratio of 2%.
・ By each 0.08% block polymer solution
A guide wire whose entire surface was coated in the same manner was produced.
【0048】図1に示される、テルモ社製カテーテル
「ハートキャス」5Frに上記の方法で得られた各ガイ
ドワイヤを挿入し、それぞれの最大抵抗値を引っ張り試
験器(島津オートグラフ AGS-100D 島津製作所製)に
て測定した。この際、カテーテル内には水道水を満た
し、挿入速度は500mm/minとした。結果をもとに得られ
た累乗近似曲線を図2に示す。図2に示される結果か
ら、湿潤時にのみ潤滑性を示す被覆樹脂のコート濃度に
より挿入抵抗が変わることがわかる。このコート濃度
は、被覆後の医療用具表面においては、樹脂の密度とし
て現れる。Each guide wire obtained by the above-mentioned method was inserted into the catheter “Heartcass” 5Fr manufactured by Terumo Corporation shown in FIG. 1, and the maximum resistance value of each was measured using a tensile tester (Shimadzu Autograph AGS-100D Shimadzu). (Manufactured by Seisakusho). At this time, the catheter was filled with tap water, and the insertion speed was 500 mm / min. FIG. 2 shows a power approximate curve obtained based on the results. From the results shown in FIG. 2, it can be seen that the insertion resistance changes depending on the coating concentration of the coating resin showing lubricity only when wet. The coating concentration appears as a resin density on the surface of the medical device after coating.
【0049】そこで、図3に示すように、全長150cmの
ガイドワイヤ1の基端側(50〜100cm)の部分には0.6%
の濃度の潤滑性樹脂被覆5を施し、先端側には2%の濃
度の潤滑性樹脂被覆6を行ったところ、操作性はきわめ
て良好なものとなった。また、2%の濃度の潤滑性樹脂
被覆と0.6%の濃度の潤滑性樹脂被覆の境に濃度勾配を
つけると、外径や摩擦抵抗に段差もなくスムーズに移行
し、より操作性は良好なものとなった。なお、ガイドワ
イヤとしては、外径0.6mmのNi−Ti製芯金2に熱可塑性
ポリウレタン樹脂3をコートし外径0.89mmとしたもの
で、先端部は芯金をテーパ状に細径化し柔軟化した上に
X線造影マーカとしてPt、Au等のコイル4を巻い
た。ポリウレタン樹脂の被覆層は先端部においても外径
が一定であるものとした。Therefore, as shown in FIG. 3, 0.6% is added to the portion of the guide wire 1 having a total length of 150 cm on the base end side (50 to 100 cm).
When the lubricating resin coating 5 having a concentration of 2% was applied, and the lubricating resin coating 6 having a concentration of 2% was formed on the front end side, the operability was extremely good. In addition, when a concentration gradient is provided between the 2% concentration lubricating resin coating and the 0.6% concentration lubricating resin coating, the outer diameter and frictional resistance smoothly transition without any level difference, and the operability is better. It became something. The guide wire is made of a Ni-Ti core 2 having an outer diameter of 0.6 mm coated with a thermoplastic polyurethane resin 3 to have an outer diameter of 0.89 mm. Then, a coil 4 of Pt, Au or the like was wound as an X-ray contrast marker. The polyurethane resin coating layer had a constant outer diameter even at the tip.
【0050】図4は本発明を適用した他の実施例を示す
ものである。先端部は表面にシリコンを被覆したプラチ
ナ(Pt)製のコイル8がNi−Ti製芯金9の先端細径部
30cmの部分に巻かれており、芯金9の他の部分は熱可塑
性ポリウレタン樹脂7によりコートされている。また、
芯金9のコイル8の基端から約50-100cmは上記実施例と
同様の潤滑性樹脂による濃度1.6%の潤滑性樹脂被覆1
0を施し、その基端側40-90cmには濃度0.4%の潤滑性樹
脂被覆11を施した。最も基端側の10cmは、潤滑性樹脂
被覆を行わなかった。先端のコイル8は先端部の形状付
け(リシェイプ)を可能とし、基端の潤滑性樹脂被覆を
行わなかった部分は、カテーテル等への挿入の際には摩
擦抵抗が阻害とならない程に短く、かつ術者の取り扱い
をより容易とするために設けられている。FIG. 4 shows another embodiment to which the present invention is applied. The tip is a platinum (Pt) coil 8 whose surface is coated with silicon.
It is wound around a 30 cm portion, and the other portion of the core metal 9 is coated with the thermoplastic polyurethane resin 7. Also,
Approximately 50-100 cm from the base end of the coil 8 of the cored bar 9 is coated with the same lubricating resin as in the above-described embodiment and has a lubricating resin coating 1 of 1.6% concentration.
0, and a lubricating resin coating 11 having a concentration of 0.4% was applied to the base side 40-90 cm. The most proximal 10 cm was not coated with a lubricating resin. The coil 8 at the distal end enables shaping (reshaping) of the distal end, and the portion of the proximal end not coated with the lubricating resin is so short that frictional resistance is not hindered when inserted into a catheter or the like. And it is provided to make the handling of the operator easier.
【0051】図5は本発明を適用した第三の実施例を示
すものである。本願は先端側のNi−Ti製芯金12と基端
側のスレンレス製芯金13をステンレス製パイプ14に
より接続したものである。芯金12の先端部は図3に示
した実施例と同様テーパー化された上にPt製コイル1
7が設けられ、全体を熱可塑性ポリウレタン樹脂16に
よりコートされている。また、パイプ14には樹脂のコ
ートがなされておらず、先端側の芯金12との接続をス
ムーズに移行させるために螺旋状の切れ込み18が入れ
られている。芯金12、13とパイプ14の接続はハン
ダ等によりなされる。芯金13の表面は先端部と同様の
ポリウレタン樹脂15によりコートされている。潤滑性
樹脂被覆は、パイプ14を境界に先端側が2.0%の潤滑
性樹脂被覆19、基端側が0.6%の滑性樹脂被覆20を
されている。このような構成により、先端部は弾性が高
く、基端部はコシの強い、操作性に優れたガイドワイヤ
を得ることが出来る。FIG. 5 shows a third embodiment to which the present invention is applied. In the present application, a Ni-Ti core metal 12 at the distal end and a stainless steel core 13 at the proximal end are connected by a stainless steel pipe 14. The tip of the core 12 is tapered similarly to the embodiment shown in FIG.
7 are provided, and the whole is coated with a thermoplastic polyurethane resin 16. Further, the pipe 14 is not coated with a resin, and has a spiral cut 18 in order to smoothly transfer the connection with the core metal 12 on the distal end side. The connection between the metal cores 12, 13 and the pipe 14 is made by soldering or the like. The surface of the metal core 13 is coated with the same polyurethane resin 15 as the tip. The lubricating resin coating has a 2.0% lubricating resin coating 19 on the distal end side and a 0.6% lubricating resin coating 20 on the proximal end side with the pipe 14 as a boundary. With such a configuration, a guide wire having high elasticity at the distal end and strong stiffness at the proximal end and excellent in operability can be obtained.
【0052】上記各実施例はガイドワイヤについてのも
のであるが、既に述べているように、カテーテルへの応
用も可能である。Although each of the above embodiments is directed to a guide wire, as described above, application to a catheter is also possible.
【0053】また、上述した実施例はいずれも、潤滑性
被覆の摩擦抵抗の変化させるために、被覆した樹脂溶液
の濃度を変えているが、先端側と基端側とで、異なる潤
滑性樹脂を被覆することにより行っても良い。In each of the above-described embodiments, the concentration of the coated resin solution is changed in order to change the frictional resistance of the lubricating coating. May be carried out.
【0054】また、上記3つの実施例における潤滑性被
覆の基端部と先端部との摩擦抵抗の大きさの比は、図2
の摺動値の大きさから明らかなように、基端:先端が
1:2程度である。この比は、操作性やカテーテル無い
の摺動性を考慮すると、1:1.2無し1:20の範囲
内であることが好ましく、最も好ましくは、1:1.5
乃至1:4.5程度、すなわち、潤滑性樹脂被覆の基端
部の摩擦抵抗が、先端部の摩擦抵抗の1.5倍以上かつ
4.5倍以下の大きさであることが好ましい。これによ
って、操作性が高く、かつ摺動性の高い、本発明の効果
をより顕著に示す医療用具を実現することができる。The ratio of the magnitude of the frictional resistance between the base end portion and the front end portion of the lubricating coating in the above three embodiments is shown in FIG.
As is clear from the magnitude of the sliding value, the ratio of the base end to the front end is about 1: 2. In consideration of operability and slidability without a catheter, this ratio is preferably in the range of 1: 1.2 and 1:20, and most preferably 1: 1.5.
It is preferable that the frictional resistance at the base end of the lubricating resin coating is 1.5 times or more and 4.5 times or less the frictional resistance at the front end. This makes it possible to realize a medical device that has high operability and high slidability and that shows the effects of the present invention more remarkably.
【0055】[0055]
【発明の効果】本発明によれば、体内に挿入する部分の
摩擦抵抗は小さく、手元部分の摩擦抵抗は大きくなり、
また、摩擦抵抗の大きい手元部分もある程度の潤滑性を
有するので、医療用具の操作性が大きく向上する。本発
明では、水溶性高分子物質の潤滑性の樹脂被覆を施した
医療用具の基端部の親水性ないし潤滑性を樹脂被覆の濃
度を薄くし潤滑性をおさえ、医療用具把持部分を滑り難
くして操作性を向上させている。According to the present invention, the frictional resistance of the part to be inserted into the body is small, and the frictional resistance of the hand part is large.
In addition, since the hand portion having a large frictional resistance also has a certain degree of lubricity, the operability of the medical device is greatly improved. In the present invention, the hydrophilicity or lubricity of the base end of a medical device coated with a lubricating resin coating of a water-soluble polymer substance is reduced in the concentration of the resin coating to reduce the lubricity, and the medical device gripping portion is less likely to slip. The operability has been improved.
【図1】本発明の効果を確認するための挿入抵抗の試験
法を示す正面図である。FIG. 1 is a front view showing a test method of insertion resistance for confirming the effect of the present invention.
【図2】ブロックポリマー濃度を重量比で変えた場合の
摺動抵抗値とブロックポリマー濃度の累乗近似曲線を示
す。FIG. 2 shows a power approximate curve of a sliding resistance value and a block polymer concentration when the block polymer concentration is changed by a weight ratio.
【図3】本発明の実施例1であるガイドワイヤを示す断
面図である。FIG. 3 is a cross-sectional view illustrating a guide wire according to the first embodiment of the present invention.
【図4】本発明の実施例2であるガイドワイヤを示す断
面図である。FIG. 4 is a sectional view showing a guide wire according to a second embodiment of the present invention.
【図5】本発明の実施例3であるガイドワイヤを示す断
面図である。FIG. 5 is a sectional view showing a guide wire according to a third embodiment of the present invention.
1:ガイドワイヤ、2:芯金、3:ポリウレタン樹脂、
4:コイル、5・6:潤滑性樹脂被覆1: guide wire, 2: core metal, 3: polyurethane resin,
4: coil, 5.6: lubricating resin coating
Claims (6)
を有する体腔内挿入用の医療用具において、該潤滑性樹
脂被覆の該医療用具上における基端側と先端側とは摩擦
抵抗が異なることを特徴とする医療用具。1. A medical device for insertion into a body cavity having a lubricating resin coating which has lubricity when wet, wherein the lubricating resin coating has different frictional resistance between a proximal end and a distal end on the medical device. Medical equipment characterized by the following.
体を被覆してなることを特徴とする請求項1記載の医療
用具。2. The medical device according to claim 1, wherein the lubricating resin coating covers the entire medical device.
基端側より高密度で被覆されている事を特徴とする請求
項1に記載の医療用具。3. The medical device according to claim 1, wherein the lubricating resin coating is more densely coated on the distal side than on the base side.
にかけて3段階以上の段階的に摩擦抵抗が小さくなるこ
とを特徴とする請求項1に記載の医療用具。4. The medical device according to claim 1, wherein the frictional resistance of the lubricating resin coating decreases in three or more steps from a base end to a tip end.
が前記潤滑性樹脂被覆を有さない前記医療用具表面の摩
擦抵抗より小さいことを特徴とする請求項1に記載の医
療用具。5. The medical device according to claim 1, wherein a frictional resistance at a base end side of the lubricating resin coating is smaller than a frictional resistance of a surface of the medical device not having the lubricating resin coating.
が、先端側の摩擦抵抗の1.2倍以上かつ20倍未満の
大きさであることを特徴とする請求項5に記載の医療用
具。6. The lubricating resin coating according to claim 5, wherein the frictional resistance on the proximal end side is at least 1.2 times and less than 20 times the frictional resistance on the distal end side. Medical tools.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP02386597A JP3432101B2 (en) | 1997-02-06 | 1997-02-06 | Medical equipment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP02386597A JP3432101B2 (en) | 1997-02-06 | 1997-02-06 | Medical equipment |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002203365A Division JP3803621B2 (en) | 2002-07-12 | 2002-07-12 | Guide wire |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH10216220A true JPH10216220A (en) | 1998-08-18 |
JP3432101B2 JP3432101B2 (en) | 2003-08-04 |
Family
ID=12122345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP02386597A Expired - Lifetime JP3432101B2 (en) | 1997-02-06 | 1997-02-06 | Medical equipment |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3432101B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998055172A3 (en) * | 1997-06-03 | 1999-10-21 | Scimed Life Systems Inc | Lubricity gradient for medical devices |
EP1488822A3 (en) * | 2003-06-18 | 2005-05-04 | Nipro Corporation | Balloon catheter suited to kissing techniques |
JP2013509218A (en) * | 2009-10-30 | 2013-03-14 | ウノメディカル アクティーゼルスカブ | Medical tubing |
CN113117154A (en) * | 2019-12-31 | 2021-07-16 | 东莞市先健医疗有限公司 | Hydrophilic coating solution, method for preparing the same, and medical device coated with the same |
-
1997
- 1997-02-06 JP JP02386597A patent/JP3432101B2/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998055172A3 (en) * | 1997-06-03 | 1999-10-21 | Scimed Life Systems Inc | Lubricity gradient for medical devices |
EP1488822A3 (en) * | 2003-06-18 | 2005-05-04 | Nipro Corporation | Balloon catheter suited to kissing techniques |
US7407507B2 (en) | 2003-06-18 | 2008-08-05 | Nipro Corporation | Balloon catheter suited to kissing techniques |
JP2013509218A (en) * | 2009-10-30 | 2013-03-14 | ウノメディカル アクティーゼルスカブ | Medical tubing |
CN113117154A (en) * | 2019-12-31 | 2021-07-16 | 东莞市先健医疗有限公司 | Hydrophilic coating solution, method for preparing the same, and medical device coated with the same |
Also Published As
Publication number | Publication date |
---|---|
JP3432101B2 (en) | 2003-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH04144567A (en) | Medical treating implement | |
US4876126A (en) | Medical instrument and method for making | |
US5441488A (en) | Medical tool having lubricious surface in a wetted state and method for production thereof | |
JP6357156B2 (en) | Medical device and manufacturing method thereof | |
AU2014247580B2 (en) | Medical device and method for producing medical device | |
EP1015060B1 (en) | Lubricity gradient for medical devices | |
JPS60259269A (en) | Medical device and its production | |
JP6619360B2 (en) | Medical device and manufacturing method thereof | |
JP2002543885A (en) | Lubricious coatings for medical devices containing anti-occlusive agents | |
JP3631781B2 (en) | Medical device whose surface has lubricity when wet | |
WO2015029625A1 (en) | Medical instrument and method for manufacturing same | |
JPS6145775A (en) | Medical tube guide and its production | |
JP3432101B2 (en) | Medical equipment | |
JP3803621B2 (en) | Guide wire | |
JP3580844B2 (en) | Medical device with lubricious surface when wet | |
JP2006192294A (en) | Guide wire | |
JP2016150163A (en) | Method of producing medical tool | |
JP3599784B2 (en) | Medical device with lubricious surface when wet | |
JP3462903B2 (en) | Medical device with lubricious surface when wet | |
JPH01195863A (en) | Medical instrument and manufacture thereof | |
JP3580843B2 (en) | Low friction medical device and method of manufacturing the same | |
JP2012161372A (en) | Medical instrument and method for manufacturing the same | |
JP2013169283A (en) | Method of manufacturing medical instrument and the medical instrument | |
JP7660447B2 (en) | Medical devices and methods for manufacturing medical devices | |
JPS61122869A (en) | Medical appliances and its production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090523 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100523 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110523 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110523 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120523 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120523 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130523 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130523 Year of fee payment: 10 |
|
EXPY | Cancellation because of completion of term |